Mechanisms of neuropathic pain

European Neuropsychopharmacology

Volumn 22, Issue 2, 2012, Pages 81-91

  Nickel, Florian T ^a   Seifert, Frank ^a   Lanz, Stefan ^a   Maihöfner, Christian ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Neuropathic pain; Pathophysiology; Reorganization; Sensitization; Sympathetically maintained; Symptoms

Indexed keywords

AMITRIPTYLINE; ARACHIDONIC ACID; BRADYKININ; CALCITONIN GENE RELATED PEPTIDE; CARBAMAZEPINE; DULOXETINE; DYNORPHIN; ENDORPHIN; GABAPENTIN; HISTAMINE; LAMOTRIGINE; LIDOCAINE; METABOTROPIC RECEPTOR 1; MEXILETINE; MORPHINE; NERVE GROWTH FACTOR; NEUROKININ; NORADRENALIN; OMEGA CONOTOXIN MVIIA; OXCARBAZEPINE; PHENYTOIN; PREGABALIN; PROSTAGLANDIN; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VANILLOID RECEPTOR 1; VENLAFAXINE;

ALLODYNIA; BRAIN STEM; COMPLEX REGIONAL PAIN SYNDROME; DYSESTHESIA; HUMAN; HYPERALGESIA; HYPESTHESIA; LIMB PAIN; LONG TERM POTENTIATION; NERVE CELL EXCITABILITY; NERVE CELL NETWORK; NERVE DEGENERATION; NERVE STIMULATION; NEUROPATHIC PAIN; NEUROPHYSIOLOGY; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NOCICEPTION; NOCICEPTIVE RECEPTOR; NONHUMAN; PAIN; PARESTHESIA; PAROXYSMAL PAIN; PATHOPHYSIOLOGY; PERIPHERAL NERVE; PHYSIOTHERAPY; PINPRICK HYPOALGESIA; PRIORITY JOURNAL; REVIEW; SENSITIZATION; SENSORY LOSS; SENSORY NERVE; SOMATOSENSORY CORTEX; SPINAL CORD DORSAL HORN; SYMPATHECTOMY; TACTILE HYPOESTHESIA; THERMAL HYPOESTHESIA; TRANSCUTANEOUS NERVE STIMULATION;

CENTRAL NERVOUS SYSTEM SENSITIZATION; HUMANS; MODELS, BIOLOGICAL; NEURALGIA; SENSORY RECEPTOR CELLS;

EID: 84855197599     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2011.05.005     Document Type: Review

References (124)

1. Abram S.E., Yaksh T.L. Systemic lidocaine blocks nerve injury-induced hyperalgesia and nociceptor-driven spinal sensitization in the rat. Anesthesiology 1994, 80:383-391. discussion 325A.
2. Amir R., Michaelis M., Devor M. Membrane potential oscillations in dorsal root ganglion neurons: role in normal electrogenesis and neuropathic pain. J Neurosci 1999, 19:8589-8596.
3. Baron R., Schattschneider J., Binder A., Siebrecht D., Wasner G. Relation between sympathetic vasoconstrictor activity and pain and hyperalgesia in complex regional pain syndromes: a case-control study. Lancet 2002, 359:1655-1660.
4. Bird E.V., Robinson P.P., Boissonade F.M. Na(v)1.7 sodium channel expression in human lingual nerve neuromas. Arch Oral Biol 2007, 52:494-502.
5. Birklein F., Weber M., Ernst M., Riedl B., Neundorfer B., Handwerker H.O. Experimental tissue acidosis leads to increased pain in complex regional pain syndrome (CRPS). Pain 2000, 87:227-234.
6. Bouhassira D. Definition and classification of neuropathic pain. Presse Med 2008, 37:311-314.
7. Brochu R.M., Dick I.E., Tarpley J.W., McGowan E., Gunner D., Herrington J., Shao P.P., Ok D., Li C., Parsons W.H., Stump G.L., Regan C.P., Lynch J.J., Lyons K.A., McManus O.B., Clark S., Ali Z., Kaczorowski G.J., Martin W.J., Priest B.T. Block of peripheral nerve sodium channels selectively inhibits features of neuropathic pain in rats. Mol Pharmacol 2006, 69:823-832.
8. Bruggemann J., Galhardo V., Apkarian A.V. Immediate reorganization of the rat somatosensory thalamus after partial ligation of sciatic nerve. J Pain 2001, 2:220-228.
9. Cepeda, M.S., Carr, D.B., Lau, J., 2005. Local anesthetic sympathetic blockade for complex regional pain syndrome. Cochrane Database Syst Rev, CD004598.
10. Costigan M., Woolf C.J. No DREAM, No pain. Closing the spinal gate. Cell 2002, 108:297-300.
11. Cox J.J., Reimann F., Nicholas A.K., Thornton G., Roberts E., Springell K., Karbani G., Jafri H., Mannan J., Raashid Y., Al-Gazali L., Hamamy H., Valente E.M., Gorman S., Williams R., McHale D.P., Wood J.N., Gribble F.M., Woods C.G. An SCN9A channelopathy causes congenital inability to experience pain. Nature 2006, 444:894-898.
12. Craig A.D. How do you feel? Interoception: the sense of the physiological condition of the body. Nat Rev Neurosci 2002, 3:655-666.
13. Craig A.D., Bushnell M.C. The thermal grill illusion: unmasking the burn of cold pain. Science 1994, 265:252-255.
14. Cruccu G., Aziz T.Z., Garcia-Larrea L., Hansson P., Jensen T.S., Lefaucheur J.P., Simpson B.A., Taylor R.S. EFNS guidelines on neurostimulation therapy for neuropathic pain. Eur J Neurol 2007, 14:952-970.
15. Cui J.G., O'Connor W.T., Ungerstedt U., Linderoth B., Meyerson B.A. Spinal cord stimulation attenuates augmented dorsal horn release of excitatory amino acids in mononeuropathy via a GABAergic mechanism. Pain 1997, 73:87-95.
16. Cummins T.R., Sheets P.L., Waxman S.G. The roles of sodium channels in nociception: Implications for mechanisms of pain. Pain 2007, 131:243-257.
17. D'Mello R., Dickenson A.H. Spinal cord mechanisms of pain. Br J Anaesth 2008, 101:8-16.
18. Dick I.E., Brochu R.M., Purohit Y., Kaczorowski G.J., Martin W.J., Priest B.T. Sodium channel blockade may contribute to the analgesic efficacy of antidepressants. J Pain 2007, 8:315-324.
19. Dubinsky R.M., Miyasaki J. Assessment: efficacy of transcutaneous electric nerve stimulation in the treatment of pain in neurologic disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2010, 74:173-176.
20. Eide P.K., Jorum E., Stubhaug A., Bremnes J., Breivik H. Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo. Pain 1994, 58:347-354.
21. Eisenberg E., Lurie Y., Braker C., Daoud D., Ishay A. Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study. Neurology 2001, 57:505-509.
22. Fertleman C.R., Baker M.D., Parker K.A., Moffatt S., Elmslie F.V., Abrahamsen B., Ostman J., Klugbauer N., Wood J.N., Gardiner R.M., Rees M. SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron 2006, 52:767-774.
23. Flor H. Phantom-limb pain: characteristics, causes, and treatment. Lancet Neurol 2002, 1:182-189.
24. Flor H., Braun C., Elbert T., Birbaumer N. Extensive reorganization of primary somatosensory cortex in chronic back pain patients. Neurosci Lett 1997, 224:5-8.
25. Flor H., Denke C., Schaefer M., Grusser S. Effect of sensory discrimination training on cortical reorganisation and phantom limb pain. Lancet 2001, 357:1763-1764.
26. Flor H., Elbert T., Knecht S., Wienbruch C., Pantev C., Birbaumer N., Larbig W., Taub E. Phantom-limb pain as a perceptual correlate of cortical reorganization following arm amputation. Nature 1995, 375:482-484.
27. Flor H., Nikolajsen L., Staehelin Jensen T. Phantom limb pain: a case of maladaptive CNS plasticity?. Nat Rev Neurosci 2006, 7:873-881.
28. Frettloh J., Huppe M., Maier C. Severity and specificity of neglect-like symptoms in patients with complex regional pain syndrome (CRPS) compared to chronic limb pain of other origins. Pain 2006, 124:184-189.
29. Freynhagen R., Baron R. The evaluation of neuropathic components in low back pain. Curr Pain Headache Rep 2009, 13:185-190.
30. Freynhagen R., Rolke R., Baron R., Tolle T.R., Rutjes A.K., Schu S., Treede R.D. Pseudoradicular and radicular low-back pain-a disease continuum rather than different entities? Answers from quantitative sensory testing. Pain 2008, 135:65-74.
31. Fundytus M.E., Fisher K., Dray A., Henry J.L., Coderre T.J. In vivo antinociceptive activity of anti-rat mGluR1 and mGluR5 antibodies in rats. Neuroreport 1998, 9:731-735.
32. Gilron I. Gabapentin and pregabalin for chronic neuropathic and early postsurgical pain: current evidence and future directions. Curr Opin Anaesthesiol 2007, 20:456-472.
33. Gilron I., Watson C.P., Cahill C.M., Moulin D.E. Neuropathic pain: a practical guide for the clinician. Cmaj 2006, 175:265-275.
34. Goldstein D.J., Lu Y., Detke M.J., Lee T.C., Iyengar S. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005, 116:109-118.
35. Guan Y., Wacnik P.W., Yang F., Carteret A.F., Chung C.Y., Meyer R.A., Raja S.N. Spinal cord stimulation-induced analgesia: electrical stimulation of dorsal column and dorsal roots attenuates dorsal horn neuronal excitability in neuropathic rats. Anesthesiology 2010, 113:1392-1405.
36. Guerrini R., Parmeggiani L. Topiramate and its clinical applications in epilepsy. Expert Opin Pharmacother 2006, 7:811-823.
37. Guo L.H., Schluesener H.J. The innate immunity of the central nervous system in chronic pain: the role of Toll-like receptors. Cell Mol Life Sci 2007, 64:1128-1136.
38. Han C., Rush A.M., Dib-Hajj S.D., Li S., Xu Z., Wang Y., Tyrrell L., Wang X., Yang Y., Waxman S.G. Sporadic onset of erythermalgia: a gain-of-function mutation in Nav1.7. Ann Neurol 2006, 59:553-558.
39. Hansson P., Backonja M., Bouhassira D. Usefulness and limitations of quantitative sensory testing: clinical and research application in neuropathic pain states. Pain 2007, 129:256-259.
40. Hong S., Morrow T.J., Paulson P.E., Isom L.L., Wiley J.W. Early painful diabetic neuropathy is associated with differential changes in tetrodotoxin-sensitive and -resistant sodium channels in dorsal root ganglion neurons in the rat. J Biol Chem 2004, 279:29341-29350.
41. Hong S., Wiley J.W. Early painful diabetic neuropathy is associated with differential changes in the expression and function of vanilloid receptor 1. J Biol Chem 2005, 280:618-627.
42. Hsieh J.C., Belfrage M., Stone-Elander S., Hansson P., Ingvar M. Central representation of chronic ongoing neuropathic pain studied by positron emission tomography. Pain 1995, 63:225-236.
43. Hucho T., Levine J.D. Signaling pathways in sensitization: toward a nociceptor cell biology. Neuron 2007, 55:365-376.
44. Hudson L.J., Bevan S., Wotherspoon G., Gentry C., Fox A., Winter J. VR1 protein expression increases in undamaged DRG neurons after partial nerve injury. Eur J Neurosci 2001, 13:2105-2114.
45. Iadarola M.J., Max M.B., Berman K.F., Byas-Smith M.G., Coghill R.C., Gracely R.H., Bennett G.J. Unilateral decrease in thalamic activity observed with positron emission tomography in patients with chronic neuropathic pain. Pain 1995, 63:55-64.
46. Inoue M., Rashid M.H., Fujita R., Contos J.J., Chun J., Ueda H. Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nat Med 2004, 10:712-718.
47. Jarvis B., Coukell A.J. Mexiletine. A review of its therapeutic use in painful diabetic neuropathy. Drugs 1998, 56:691-707.
48. Jarvis M.F., Honore P., Shieh C.C., Chapman M., Joshi S., Zhang X.F., Kort M., Carroll W., Marron B., Atkinson R., Thomas J., Liu D., Krambis M., Liu Y., McGaraughty S., Chu K., Roeloffs R., Zhong C., Mikusa J.P., Hernandez G., Gauvin D., Wade C., Zhu C., Pai M., Scanio M., Shi L., Drizin I., Gregg R., Matulenko M., Hakeem A., Gross M., Johnson M., Marsh K., Wagoner P.K., Sullivan J.P., Faltynek C.R., Krafte D.S. A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat. Proc Natl Acad Sci USA 2007, 104:8520-8525.
49. Julius D., Basbaum A.I. Molecular mechanisms of nociception. Nature 2001, 413:203-210.
50. Kawasaki Y., Xu Z.Z., Wang X., Park J.Y., Zhuang Z.Y., Tan P.H., Gao Y.J., Roy K., Corfas G., Lo E.H., Ji R.R. Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat Med 2008, 14:331-336.
51. Khasabov S.G., Rogers S.D., Ghilardi J.R., Peters C.M., Mantyh P.W., Simone D.A. Spinal neurons that possess the substance P receptor are required for the development of central sensitization. J Neurosci 2002, 22:9086-9098.
52. Kiefer R.T., Rohr P., Ploppa A., Dieterich H.J., Grothusen J., Koffler S., Altemeyer K.H., Unertl K., Schwartzman R.J. Efficacy of ketamine in anesthetic dosage for the treatment of refractory complex regional pain syndrome: an open-label phase II study. Pain Med 2008, 9:1173-1201.
53. Knabl J., Witschi R., Hosl K., Reinold H., Zeilhofer U.B., Ahmadi S., Brockhaus J., Sergejeva M., Hess A., Brune K., Fritschy J.M., Rudolph U., Mohler H., Zeilhofer H.U. Reversal of pathological pain through specific spinal GABAA receptor subtypes. Nature 2008, 451:330-334.
54. Knecht S., Henningsen H., Hohling C., Elbert T., Flor H., Pantev C., Taub E. Plasticity of plasticity? Changes in the pattern of perceptual correlates of reorganization after amputation. Brain 1998, 121(Pt 4):717-724.
55. Koppert W., Dern S.K., Sittl R., Albrecht S., Schuttler J., Schmelz M. A new model of electrically evoked pain and hyperalgesia in human skin: the effects of intravenous alfentanil, S(+)-ketamine, and lidocaine. Anesthesiology 2001, 95:395-402.
56. Kurvers H.A., Jacobs M.J., Beuk R.J., Van den Wildenberg F.A., Kitslaar P.J., Slaaf D.W., Reneman R.S. Reflex sympathetic dystrophy: evolution of microcirculatory disturbances in time. Pain 1995, 60:333-340.
57. Lai J., Luo M.C., Chen Q., Ma S., Gardell L.R., Ossipov M.H., Porreca F. Dynorphin A activates bradykinin receptors to maintain neuropathic pain. Nat Neurosci 2006, 9:1534-1540.
58. Lingueglia E. Acid-sensing ion channels in sensory perception. J Biol Chem 2007, 282:17325-17329.
59. Lumpkin E.A., Caterina M.J. Mechanisms of sensory transduction in the skin. Nature 2007, 445:858-865.
60. Luo Z.D., Chaplan S.R., Higuera E.S., Sorkin L.S., Stauderman K.A., Williams M.E., Yaksh T.L. Upregulation of dorsal root ganglion (alpha)2(delta) calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats. J Neurosci 2001, 21:1868-1875.
61. Maihofner C., Baron R., DeCol R., Binder A., Birklein F., Deuschl G., Handwerker H.O., Schattschneider J. The motor system shows adaptive changes in complex regional pain syndrome. Brain 2007, 130:2671-2687.
62. Maihofner C., Handwerker H.O., Neundorfer B., Birklein F. Patterns of cortical reorganization in complex regional pain syndrome. Neurology 2003, 61:1707-1715.
63. Maihofner C., Handwerker H.O., Neundorfer B., Birklein F. Cortical reorganization during recovery from complex regional pain syndrome. Neurology 2004, 63:693-701.
64. Maihofner C., Neundorfer B., Birklein F., Handwerker H.O. Mislocalization of tactile stimulation in patients with complex regional pain syndrome. J Neurol 2006, 253:772-779.
65. Malan T.P., Ossipov M.H., Gardell L.R., Ibrahim M., Bian D., Lai J., Porreca F. Extraterritorial neuropathic pain correlates with multisegmental elevation of spinal dynorphin in nerve-injured rats. Pain 2000, 86:185-194.
66. Manfredi M., Bini G., Cruccu G., Accornero N., Berardelli A., Medolago L. Congenital absence of pain. Arch Neurol 1981, 38:507-511.
67. Matthews E.A., Dickenson A.H. Effects of spinally delivered N- and P-type voltage-dependent calcium channel antagonists on dorsal horn neuronal responses in a rat model of neuropathy. Pain 2001, 92:235-246.
68. McCabe C.S., Haigh R.C., Blake D.R. Mirror visual feedback for the treatment of complex regional pain syndrome (type 1). Curr Pain Headache Rep 2008, 12:103-107.
69. McDermott A.M., Toelle T.R., Rowbotham D.J., Schaefer C.P., Dukes E.M. The burden of neuropathic pain: results from a cross-sectional survey. Eur J Pain 2006, 10:127-135.
70. Miao F.J., Janig W., Levine J. Role of sympathetic postganglionic neurons in synovial plasma extravasation induced by bradykinin. J Neurophysiol 1996, 75:715-724.
71. Moalem G., Tracey D.J. Immune and inflammatory mechanisms in neuropathic pain. Brain Res Rev 2006, 51:240-264.
72. Ossipov M.H., Lai J., Malan T.P., Porreca F. Spinal and supraspinal mechanisms of neuropathic pain. Ann N Y Acad Sci 2000, 909:12-24.
73. Pan H.L., Wu Z.Z., Zhou H.Y., Chen S.R., Zhang H.M., Li D.P. Modulation of pain transmission by G-protein-coupled receptors. Pharmacol Ther 2008, 117:141-161.
74. Pezet S., McMahon S.B. Neurotrophins: mediators and modulators of pain. Annu Rev Neurosci 2006, 29:507-538.
75. Ramachandran V.S., Altschuler E.L. The use of visual feedback, in particular mirror visual feedback, in restoring brain function. Brain 2009, 132:1693-1710.
76. Ramachandran V.S., Stewart M., Rogers-Ramachandran D.C. Perceptual correlates of massive cortical reorganization. Neuroreport 1992, 3:583-586.
77. Ramer M.S., Thompson S.W., McMahon S.B. Causes and consequences of sympathetic basket formation in dorsal root ganglia. Pain 1999, Suppl 6:S111-S120.
78. Raskin P., Donofrio P.D., Rosenthal N.R., Hewitt D.J., Jordan D.M., Xiang J., Vinik A.I. Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology 2004, 63:865-873.
79. Rauck R.L., Wallace M.S., Leong M.S., Minehart M., Webster L.R., Charapata S.G., Abraham J.E., Buffington D.E., Ellis D., Kartzinel R. A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain. J Pain Symptom Manage 2006, 31:393-406.
80. Rice A.S., Hill R.G. New treatments for neuropathic pain. Annu Rev Med 2006, 57:535-551.
81. Ro L.S., Chen S.T., Tang L.M., Jacobs J.M. Effect of NGF and anti-NGF on neuropathic pain in rats following chronic constriction injury of the sciatic nerve. Pain 1999, 79:265-274.
82. Rogers M., Tang L., Madge D.J., Stevens E.B. The role of sodium channels in neuropathic pain. Semin Cell Dev Biol 2006, 17:571-581.
83. Rolke R., Magerl W., Campbell K.A., Schalber C., Caspari S., Birklein F., Treede R.D. Quantitative sensory testing: a comprehensive protocol for clinical trials. Eur J Pain 2006, 10:77-88.
84. Rowbotham M.C., Goli V., Kunz N.R., Lei D. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain 2004, 110:697-706.
85. Roza C., Laird J.M., Souslova V., Wood J.N., Cervero F. The tetrodotoxin-resistant Na+channel Nav1.8 is essential for the expression of spontaneous activity in damaged sensory axons of mice. J Physiol 2003, 550:921-926.
86. Sato J., Perl E.R. Adrenergic excitation of cutaneous pain receptors induced by peripheral nerve injury. Science 1991, 251:1608-1610.
87. Schmidt R., Schmelz M., Forster C., Ringkamp M., Torebjork E., Handwerker H. Novel classes of responsive and unresponsive C nociceptors in human skin. J Neurosci 1995, 15:333-341.
88. Scholz J., Mannion R.J., Hord D.E., Griffin R.S., Rawal B., Zheng H., Scoffings D., Phillips A., Guo J., Laing R.J., Abdi S., Decosterd I., Woolf C.J. A novel tool for the assessment of pain: validation in low back pain. PLoS Med 2009, 6:e1000047.
89. Scholz J., Woolf C.J. The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 2007, 10:1361-1368.
90. Seifert F., Kiefer G., DeCol R., Schmelz M., Maihofner C. Differential endogenous pain modulation in complex-regional pain syndrome. Brain 2009, 132:788-800.
91. Seifert F., Maihofner C. Central mechanisms of experimental and chronic neuropathic pain: findings from functional imaging studies. Cell Mol Life Sci 2009, 66:375-390.
92. Shinder V., Govrin-Lippmann R., Cohen S., Belenky M., Ilin P., Fried K., Wilkinson H.A., Devor M. Structural basis of sympathetic-sensory coupling in rat and human dorsal root ganglia following peripheral nerve injury. J Neurocytol 1999, 28:743-761.
93. Simpson D.M., McArthur J.C., Olney R., Clifford D., So Y., Ross D., Baird B.J., Barrett P., Hammer A.E. Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial. Neurology 2003, 60:1508-1514.
94. Sommer C., Kress M. Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci Lett 2004, 361:184-187.
95. Susser E., Sprecher E., Yarnitsky D. Paradoxical heat sensation in healthy subjects: peripherally conducted by A delta or C fibres?. Brain 1999, 122(Pt 2):239-246.
96. Suzuki R., Hunt S.P., Dickenson A.H. The coding of noxious mechanical and thermal stimuli of deep dorsal horn neurones is attenuated in NK1 knockout mice. Neuropharmacology 2003, 45:1093-1100.
97. Tal M., Wall P.D., Devor M. Myelinated afferent fiber types that become spontaneously active and mechanosensitive following nerve transection in the rat. Brain Res 1999, 824:218-223.
98. Tecchio F., Padua L., Aprile I., Rossini P.M. Carpal tunnel syndrome modifies sensory hand cortical somatotopy: a MEG study. Hum Brain Mapp 2002, 17:28-36.
99. Thienel U., Neto W., Schwabe S.K., Vijapurkar U. Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials. Acta Neurol Scand 2004, 110:221-231.
100. Torebjork E., Wahren L., Wallin G., Hallin R., Koltzenburg M. Noradrenaline-evoked pain in neuralgia. Pain 1995, 63:11-20.
101. Torrance N., Smith B.H., Bennett M.I., Lee A.J. The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain 2006, 7:281-289.
102. Tracey I., Mantyh P.W. The cerebral signature for pain perception and its modulation. Neuron 2007, 55:377-391.
103. Treede R.D., Jensen T.S., Campbell J.N., Cruccu G., Dostrovsky J.O., Griffin J.W., Hansson P., Hughes R., Nurmikko T., Serra J. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008, 70:1630-1635.
104. Tremont-Lukats I.W., Challapalli V., McNicol E.D., Lau J., Carr D.B. Systemic administration of local anesthetics to relieve neuropathic pain: a systematic review and meta-analysis. Anesth Analg 2005, 101:1738-1749.
105. Tsuda M., Inoue K., Salter M.W. Neuropathic pain and spinal microglia: a big problem from molecules in "small" glia. Trends Neurosci 2005, 28:101-107.
106. Ueda H. Peripheral mechanisms of neuropathic pain - involvement of lysophosphatidic acid receptor-mediated demyelination. Mol Pain 2008, 4:11.
107. Vanderah T.W., Gardell L.R., Burgess S.E., Ibrahim M., Dogrul A., Zhong C.M., Zhang E.T., Malan T.P., Ossipov M.H., Lai J., Porreca F. Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance. J Neurosci 2000, 20:7074-7079.
108. Vanegas H., Schaible H.G. Descending control of persistent pain: inhibitory or facilitatory?. Brain Res Brain Res Rev 2004, 46:295-309.
109. Vestergaard K., Andersen G., Gottrup H., Kristensen B.T., Jensen T.S. Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology 2001, 56:184-190.
110. White D.M., Leah J.D., Zimmermann M. The localization and release of substance P and calcitonin gene-related peptide at nerve fibre endings in rat cutaneous nerve neuroma. Brain Res 1989, 503:198-204.
111. Wiffen, P.J., Rees, J., 2007. Lamotrigine for acute and chronic pain. Cochrane Database Syst Rev, CD006044.
112. Wood J.N., Boorman J.P., Okuse K., Baker M.D. Voltage-gated sodium channels and pain pathways. J Neurobiol 2004, 61:55-71.
113. Woolf C.J., Decosterd I. Implications of recent advances in the understanding of pain pathophysiology for the assessment of pain in patients. Pain 1999, Suppl 6:S141-S147.
114. Woolf C.J., Mannion R.J. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999, 353:1959-1964.
115. Woolf C.J., Salter M.W. Neuronal plasticity: increasing the gain in pain. Science 2000, 288:1765-1769.
116. Wu W.L., Burnett D.A., Domalski M., Greenlee W.J., Li C., Bertorelli R., Fredduzzi S., Lozza G., Veltri A., Reggiani A. Discovery of orally efficacious tetracyclic metabotropic glutamate receptor 1 (mGluR1) antagonists for the treatment of chronic pain. J Med Chem 2007, 50:5550-5553.
117. Xing H., Chen M., Ling J., Tan W., Gu J.G. TRPM8 mechanism of cold allodynia after chronic nerve injury. J Neurosci 2007, 27:13680-13690.
118. Yang Y., Wang Y., Li S., Xu Z., Li H., Ma L., Fan J., Bu D., Liu B., Fan Z., Wu G., Jin J., Ding B., Zhu X., Shen Y. Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J Med Genet 2004, 41:171-174.
119. Yarnitsky D. Quantitative sensory testing. Muscle Nerve 1997, 20:198-204.
120. Zeilhofer H.U. Loss of glycinergic and GABAergic inhibition in chronic pain-contributions of inflammation and microglia. Int Immunopharmacol 2008, 8:182-187.
121. Zeilhofer, H.U., Witschi, R., Hosl, K., 2009. Subtype-selective GABA(A) receptor mimetics-novel antihyperalgesic agents? J Mol Med.
122. Zimmermann K., Leffler A., Babes A., Cendan C.M., Carr R.W., Kobayashi J., Nau C., Wood J.N., Reeh P.W. Sensory neuron sodium channel Nav1.8 is essential for pain at low temperatures. Nature 2007, 447:855-858.
123. Zimmermann M. Pathobiology of neuropathic pain. Eur J Pharmacol 2001, 429:23-37.
124. Zurborg S., Yurgionas B., Jira J.A., Caspani O., Heppenstall P.A. Direct activation of the ion channel TRPA1 by Ca2+. Nat Neurosci 2007, 10:277-279.